17.17
6.12%
1.00
前日終値:
$16.17
開ける:
$16.22
24時間の取引高:
286.01K
Relative Volume:
0.77
時価総額:
$446.40M
収益:
$157.75M
当期純損益:
$-29.73M
株価収益率:
5.7425
EPS:
2.99
ネットキャッシュフロー:
$-21.00M
1週間 パフォーマンス:
-6.43%
1か月 パフォーマンス:
-17.82%
6か月 パフォーマンス:
-42.51%
1年 パフォーマンス:
-25.20%
Arcturus Therapeutics Holdings Inc Stock (ARCT) Company Profile
名前
Arcturus Therapeutics Holdings Inc
セクター
電話
(858) 900-2660
住所
10628 SCIENCE CENTER DRIVE, SAN DIEGO, CA
ARCT を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
ARCT | 17.17 | 446.40M | 157.75M | -29.73M | -21.00M | 2.99 |
VRTX | 449.66 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 746.01 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 599.51 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.36 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 108.11 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Arcturus Therapeutics Holdings Inc Stock (ARCT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-07-24 | 開始されました | William Blair | Outperform |
2023-05-11 | アップグレード | H.C. Wainwright | Neutral → Buy |
2022-11-14 | 再開されました | Wells Fargo | Overweight |
2022-11-10 | ダウングレード | Robert W. Baird | Neutral → Underperform |
2022-11-03 | アップグレード | Citigroup | Neutral → Buy |
2022-11-02 | アップグレード | Barclays | Underweight → Equal Weight |
2022-08-10 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2022-07-19 | 再開されました | Cantor Fitzgerald | Overweight |
2022-05-11 | アップグレード | Robert W. Baird | Underperform → Neutral |
2022-04-21 | ダウングレード | Citigroup | Buy → Neutral |
2022-01-31 | アップグレード | Raymond James | Underperform → Mkt Perform |
2021-08-12 | ダウングレード | Raymond James | Mkt Perform → Underperform |
2021-08-11 | ダウングレード | Goldman | Neutral → Sell |
2021-08-10 | ダウングレード | Robert W. Baird | Neutral → Underperform |
2021-07-02 | 開始されました | Cantor Fitzgerald | Overweight |
2021-06-25 | 再開されました | Goldman | Neutral |
2021-06-21 | ダウングレード | Barclays | Equal Weight → Underweight |
2021-06-04 | 再開されました | Robert W. Baird | Neutral |
2021-02-17 | ダウングレード | B. Riley Securities | Neutral → Sell |
2021-01-19 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-01-15 | ダウングレード | B. Riley Securities | Buy → Neutral |
2021-01-07 | 開始されました | Wells Fargo | Overweight |
2020-12-29 | ダウングレード | Barclays | Overweight → Equal Weight |
2020-12-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2020-12-29 | ダウングレード | Raymond James | Outperform → Mkt Perform |
2020-12-29 | ダウングレード | Robert W. Baird | Outperform → Neutral |
2020-12-23 | ダウングレード | ROTH Capital | Buy → Sell |
2020-12-08 | 繰り返されました | B. Riley Securities | Buy |
2020-12-07 | 繰り返されました | B. Riley Securities | Buy |
2020-10-26 | 開始されました | Barclays | Overweight |
2020-10-06 | 開始されました | Citigroup | Buy |
2020-08-26 | 開始されました | Piper Sandler | Overweight |
2020-07-30 | 再開されました | ROTH Capital | Buy |
2020-07-16 | 開始されました | Raymond James | Outperform |
2020-07-13 | 開始されました | B. Riley FBR | Buy |
2020-06-09 | ダウングレード | WBB Securities | Buy → Hold |
2020-02-11 | 開始されました | Robert W. Baird | Outperform |
2020-02-07 | 開始されました | Guggenheim | Buy |
2020-02-06 | 開始されました | Guggenheim | Buy |
2019-04-05 | 開始されました | H.C. Wainwright | Buy |
2018-09-20 | アップグレード | WBB Securities | Buy → Strong Buy |
2018-01-22 | 開始されました | Chardan Capital Markets | Buy |
すべてを表示
Arcturus Therapeutics Holdings Inc (ARCT) 最新ニュース
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference - Yahoo Finance
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference | ARCT Stock News - StockTitan
Sumitomo Mitsui Trust Group Inc. Buys 712,650 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat
Avian Flu: FDA Authorizes Self-Replicating Vaccine Trial to Bill Gates-Backed Company, "Study Can Proceed" - presskit.it
Arcturus: LUNAR-CF For CF Presses On With 1st Half Of 2025 Interim Data (NASDAQ:ARCT) - Seeking Alpha
Meiji Seika Pharma Invests in ARCALIS to Boost Japan's mRNA Vaccine Production | ARCT Stock News - StockTitan
Arcturus gains IND clearance for H5N1 influenza sa-RNA vaccine candidate - BioWorld Online
Possible Signal As Arcturus Therapeutics Holdings Insiders Sell US$1.6m In Stock - Simply Wall St
Another Avian Influenza mRNA Vaccine Candidate Advances - Precision Vaccinations
Arcturus Gets FDA Green Light for H5N1 Flu mRNA Vaccine Trial, Backed by BARDA | ARCT Stock News - StockTitan
What is HC Wainwright's Estimate for ARCT FY2028 Earnings? - MarketBeat
Arcturus Therapeutics’ (ARCT) Buy Rating Reiterated at HC Wainwright - Defense World
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial - Business Wire
Earnings call: Arcturus Therapeutics reported a net loss of $6.9 million - Investing.com Australia
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q3 2024 Earnings Call Transcript - Insider Monkey
Nikko Asset Management Americas, Inc. Expands Stake in Arcturus Therapeutics Holdings Inc. - GuruFocus.com
Arcturus Therapeutics (NASDAQ:ARCT) Receives "Buy" Rating from HC Wainwright - MarketBeat
ARK Investment Management LLC Has $48.77 Million Stake in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives $71.40 Average Target Price from Brokerages - Defense World
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call - GuruFocus.com
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... - Yahoo Finance UK
Arcturus Therapeutics Reports Q3 2024 Financial Results and Milestones - TipRanks
Arcturus Therapeutics Holdings Inc earnings beat by $0.31, revenue fell short of estimates - Investing.com
ARCTArcturus Therapeutics Holdings Inc. Latest Stock News & Market Updates - StockTitan
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance
Arcturus Therapeutics: Q3 Earnings Snapshot - Marketscreener.com
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress - Business Wire
Arcturus Therapeutics Holdings Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect - MSN
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Repor - GuruFocus.com
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Sumitomo Mitsui Trust Group, Inc. Expands Investment in Arcturus Therapeutics Holdings Inc. - GuruFocus.com
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Given Average Recommendation of "Buy" by Analysts - MarketBeat
Empire Life Investments Inc. Purchases New Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat
Arcturus Therapeutics (ARCT) Scheduled to Post Earnings on Thursday - MarketBeat
Arcturus Therapeutics (NASDAQ:ARCT) Shares Pass Below Two Hundred Day Moving AverageHere's Why - MarketBeat
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 - Business Wire
Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Arcturus falls after detailed Phase 1 data for cystic fibrosis therapy - MSN
Leerink Partners Initiates Coverage of Arcturus Therapeutics Holdings (ARCT) with Outperform Recommendation - MSN
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 6.1%What's Next? - MarketBeat
Investing in Arcturus Therapeutics Holdings (NASDAQ:ARCT) five years ago would have delivered you a 76% gain - Yahoo Finance
8,235 Shares in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Acquired by SG Americas Securities LLC - Defense World
A slow start for self-amplifying mRNA vaccines - Yahoo Finance
Vontobel Holding Ltd. Trims Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World
Arcturus Therapeutics (NASDAQ:ARCT) Shares Down 5.8% Following Insider Selling - MarketBeat
AQR Capital Management LLC Has $285,000 Stock Position in Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - MarketBeat
Insider Sale at Arcturus Therapeutics Holdings Inc (ARCT) - GuruFocus.com
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) COO Pad Chivukula Sells 12,000 Shares - MarketBeat
Arcturus Therapeutics executive sells $249,121 in stock By Investing.com - Investing.com Canada
Arcturus Therapeutics Holdings Inc (ARCT) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):